Company profile

Radformation

Medical Imaging & Radiology

Company profile

About Radformation

Radformation is a healthcare technology company specializing in intelligent automation software for radiation oncology. Founded in 2016 by a team of clinical physicists, the company develops solutions that streamline the entire cancer treatment planning workflow—from contouring and planning to evaluation, treatment monitoring, and billing QA. Their comprehensive product suite includes AutoContour for automated AI contouring with 480+ structure models, EZFluence and OptiPlan for automated 3D and VMAT planning, ClearCheck and ClearCalc for plan evaluation and independent calculations, ChartCheck for automated treatment evaluation and adaptive assessment, RadMachine for comprehensive machine QA, and QuickCode for billing QA. The company's mission is to make high-quality cancer care accessible everywhere by automating and standardizing treatment planning workflows. Radformation's tools are designed to be user-friendly, clinically relevant, and integrate seamlessly with Eclipse TPS. Used daily in thousands of clinics worldwide, their software helps reduce errors, increase efficiency, and enable cancer clinics to support higher patient throughput while maintaining the highest standards of care. The company is headquartered in New York and has grown to over 200 team members, serving more than 2,000 clinic installations globally including international markets.

Company description Radformation official website

Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Radformation?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Cancer
  • Radiation Oncology

Who it serves

  • Cancer Clinics
  • Health Systems
  • Radiation Oncology Departments

Deployment & integration

Deployment information is currently being developed.

Recorded integration context: Eclipse TPS.

Geographic context

MarketsAPAC · EMEA · LATAM · United States
Company sourceOfficial website

Company milestones

Platform expansion

Acquired Limbus AI in 2024. Reached 2,000 clinic installations in 2024. Grew to 200 team members in 2025. Launched ChartCheck Adaptive in 2025. Launched RadMonteCarlo in 2022. Launched RadMachine in 2022.

Partnerships

Recorded partners

No partners are currently listed.

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

No source-backed Company products are currently listed.

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Increased plan quality

Automated planning and evaluation tools

Increased safety

Automated checks and independent calculations

Increased efficiency

Automation of treatment planning workflow

Higher patient throughput

Streamlined clinical workflow

Cost savings

Automated billing QA and workflow optimization

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from Radformation

Recent articles published on Radformation's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Medical Imaging & Radiology

Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon